JENNIFER HOWELL: Open Payments
NPI 1568647204 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$934 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $248 · 2025 $934
Food & beverage: $934
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $284 |
| Amgen Inc. | 12 | $153 |
| Novo Nordisk Inc | 6 | $140 |
| UCB, Inc. | 6 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $46 |
| Octapharma USA, Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $23 |
| Radius Health, Inc. | 1 | $20 |
Products named: RINVOQ, Bimzelx, OTEZLA, Ozempic, ENBREL, TREMFYA, OCTAGAM IMMUNE GLOBULIN (HUMAN), Wegovy.
Industry payments across NC — which companies pay providers there.
